The molecular basis of catecholaminergic polymorphic ventricular tachycardia: What are the different hypotheses regarding mechanisms?

Heart Rhythm

Volumn 4, Issue 6, 2007, Pages 794-797

  Wehrens, Xander H T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genetics; Knockin mice; Molecular physiology; Polymorphic VT

Indexed keywords

CALCIUM; HYBRID PROTEIN; RYANODINE RECEPTOR 2;

ADRENERGIC STIMULATION; ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; CARBOXY TERMINAL SEQUENCE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CENTRAL CORE DISEASE; CYTOSOL; HEART DEPOLARIZATION; HUMAN; MALIGNANT HYPERTHERMIA; MISSENSE MUTATION; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION;

CALCIUM CHANNELS; CATECHOLAMINES; DEATH, SUDDEN, CARDIAC; HUMANS; MUTATION; POLYMORPHISM, GENETIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SYNCOPE; TACHYCARDIA, VENTRICULAR;

EID: 34249718261     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.12.016     Document Type: Article

References (42)

1. Coumel P., Fidelle J., and Lucet V. Catecholaminergic-induced severe ventricular arrhythmias with Adam-Stokes syndrome in children: report of four cases. Br Heart J 40 (1978) 28-37
2. Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F., Larderet G., Brahmbhatt B., Brown K., Bauce B., Muriago M., Basso C., Thiene G., Danieli G.A., and Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
3. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., Sorrentino V.V., and Danieli G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
4. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., Donarum E.A., Marino M., Tiso N., Viitasalo M., Toivonen L., Stephan D.A., and Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103 (2001) 485-490
5. Lahat H., Pras E., Olender T., Avidan N., Ben-Asher E., Man O., Levy-Nissenbaum E., Khoury A., Lorber A., Goldman B., Lancet D., and Eldar M. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 69 (2001) 1378-1384
6. Slupsky J.R., Ohnishi M., Carpenter M.R., and Reithmeier R.A. Characterization of cardiac calsequestrin. Biochemistry 26 (1987) 6539-6544
7. Liu N., Colombi B., Memmi M., Zissimopoulos S., Rizzi N., Negri S., Imbriani M., Napolitano C., Lai F.A., and Priori S.G. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 99 (2006) 292-298
8. Wehrens X.H., Lehnart S.E., and Marks A.R. Ryanodine receptor-targeted anti-arrhythmic therapy. Ann N Y Acad Sci 1047 (2005) 366-375
9. Jiang D., Xiao B., Zhang L., and Chen S.R. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 91 (2002) 218-225
10. Jiang D., Xiao B., Yang D., Wang R., Choi P., Zhang L., Cheng H., and Chen S.R. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A 101 (2004) 13062-13067
11. George C.H., Higgs G.V., and Lai F.A. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 93 (2003) 531-540
12. Kannankeril P., Mitchell B., Goonasekera S., Chelu M., Zhang W., Sood S., Kearney D., Danila C., De Beasi M., Wehrens X.H., Pautler R., Roden D., Taffet G.E., Dirksen R., Anderson M.E., and Hamilton S.L. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and mild cardiomyopathy. Proc Natl Acad Sci U S A 103 (2006) 12179-12184
13. Scoote M., and Williams A.J. The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis. Cardiovasc Res 56 (2002) 359-372
14. Lehnart S.E., Terrenoire C., Reiken S., Wehrens X.H., Song L.S., Tillman E.J., Mancarella S., Coromilas J., Lederer W.J., Kass R.S., and Marks A.R. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci U S A 103 (2006) 7906-7910
15. Cerrone M., Colombi B., Santoro M., di Barletta M.R., Scelsi M., Villani L., Napolitano C., and Priori S.G. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 96 (2005) e77-e82
16. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
17. Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F., Gasparini M., DeSimone L., Coltorti F., Bloise R., Keegan R., Cruz Filho F.E., Vignati G., Benatar A., and DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106 (2002) 69-74
18. Sumitomo N., Harada K., Nagashima M., Yasuda T., Nakamura Y., Aragaki Y., Saito A., Kurosaki K., Jouo K., Koujiro M., Konishi S., Matsuoka S., Oono T., Hayakawa S., Miura M., Ushinohama H., Shibata T., and Niimura I. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89 (2003) 66-70
19. Wehrens X.H., Lehnart S.E., Huang F., Vest J.A., Reiken S.R., Mohler P.J., Sun J., Guatimosim S., Song L.S., Rosemblit N., D'Armiento J.M., Napolitano C., Memmi M., Priori S.G., Lederer W.J., and Marks A.R. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113 (2003) 829-840
20. Lehnart S.E., Wehrens X.H.T., Laitinen P.J., Reiken S.R., Deng S.X., Chen Z., Landry D.W., Kontula K., Swan H., and Marks A.R. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation (2004) r113-r119
21. George C.H., Jundi H., Walters N., Thomas N.L., West R.R., and Lai F.A. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction. Circ Res 98 (2006) 88-97
22. Jiang D., Wang R., Xiao B., Kong H., Hunt D.J., Choi P., Zhang L., and Chen S.R. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 97 (2005) 1173-1181
23. Milting H., Lukas N., Klauke B., Korfer R., Perrot A., Osterziel K.J., Vogt J., Peters S., Thieleczek R., and Varsanyi M. Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res 71 (2006) 496-505
24. Duke A.M., Hopkins P.M., and Steele D.S. Effects of Mg(2+) and SR luminal Ca(2+) on caffeine-induced Ca(2+) release in skeletal muscle from humans susceptible to malignant hyperthermia. J Physiol 544 Pt 1 (2002) 85-95
25. Thomas N.L., Lai F.A., and George C.H. Differential Ca2+ sensitivity of RyR2 mutations reveals distinct mechanisms of channel dysfunction in sudden cardiac death. Biochem Biophys Res Commun 331 (2005) 231-238
26. Terentyev D., Viatchenko-Karpinski S., Gyorke I., Volpe P., Williams S.C., and Gyorke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A 100 (2003) 11759-11764
27. Terentyev D., Nori A., Santoro M., Viatchenko-Karpinski S., Kubalova Z., Gyorke I., Terentyeva R., Vedamoorthyrao S., Blom N.A., Valle G., Napolitano C., Williams S.C., Volpe P., Priori S.G., and Gyorke S. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 98 (2006) 1151-1158
28. Knollmann B.C., Chopra N., Hlaing T., Akin B., Yang T., Ettensohn K., Knollmann B.E., Horton K.D., Weissman N.J., Holinstat I., Zhang W., Roden D.M., Jones L.R., Franzini-Armstrong C., and Pfeifer K. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 116 (2006) 2510-2520
29. Chelu M.G., Danila C.I., Gilman C.P., and Hamilton S.L. Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc Med 14 (2004) 227-234
30. Wehrens X.H., Lehnart S.E., Reiken S.R., Deng S.X., Vest J.A., Cervantes D., Coromilas J., Landry D.W., and Marks A.R. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304 (2004) 292-296
31. Wehrens X.H., and Marks A.R. Novel therapeutic approaches for heart failure by normalising calcium cycling. Nat Rev Drug Discov 3 (2004) 565-573
32. Yano M., Kobayashi S., Kohno M., Doi M., Tokuhisa T., Okuda S., Suetsugu M., Hisaoka T., Obayashi M., Ohkusa T., and Matsuzaki M. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107 (2003) 477-484
33. Huang F., Shan J., Reiken S., Wehrens X.H., and Marks A.R. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: Rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci U S A (2006) Feb 15
34. 2+ leak from the sarcoplasmic reticulum and increases contractility. Circ Res 88 (2001) 188-194
35. Yamamoto T., and Ikemoto N. Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor. Biochem Biophys Res Commun 291 (2002) 1102-1108
36. Yang Z., Ikemoto N., Lamb G.D., and Steele D.S. The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes. Cardiovasc Res 70 (2006) 475-485
37. Fernandez-Velasco M., Gomez A.M., and Richard S. Unzipping RyR2 in adult cardiomyocytes: getting closer to mechanisms of inherited ventricular arrhythmias?. Cardiovasc Res 70 (2006) 407-409
38. Corrado D., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 113 (2006) 1634-1637
39. Bauce B., Rampazzo A., Basso C., Bagattin A., Daliento L., Tiso N., Turrini P., Thiene G., Danieli G.A., and Nava A. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 40 (2002) 341-349
40. Priori S.G., and Napolitano C. Intracellular calcium handling dysfunction and arrhythmogenesis: a new challenge for the electrophysiologist. Circ Res 97 (2005) 1077-1079
41. Tester D.J., Kopplin L.J., Creighton W., Burke A.P., and Ackerman M.J. Pathogenesis of unexplained drowning: new insights from a molecular autopsy. Mayo Clin Proc 80 5 (2005) 596-600
42. Thomas N.L., George C.H., and Lai F.A. Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death. Cardiovasc Res 64 1 (2004) 52-60